Barr investigating sources for delta-8,9 DHES for conjugated estrogens, firm tells AMEX conference.
Executive Summary
BARR LABS INVESTIGATING GENERIC CONJUGATED ESTROGENS CONTAINING DELTA-8,9 DHES, CEO Bruce Downey suggested Jan. 18 at the American Stock Exchange health care conference in New York City. When asked what Barr would do if FDA decided conjugated estrogens must contain delta-8,9, Downey responded: "Be the first to have it." On whether the company has a source, Downey said "we're working on it. We are not waiting."